These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
558 related items for PubMed ID: 26847116
21. Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry. Rudolph T, Droppa M, Baan J, Nielsen NE, Baranowski J, Hachaturyan V, Kurucova J, Hack L, Bramlage P, Geisler T. Open Heart; 2023 Feb; 10(1):. PubMed ID: 36750275 [Abstract] [Full Text] [Related]
23. Severe conduction defects requiring permanent pacemaker implantation in patients with a new-onset left bundle branch block after transcatheter aortic valve implantation. Nijenhuis VJ, Van Dijk VF, Chaldoupi SM, Balt JC, Ten Berg JM. Europace; 2017 Jun 01; 19(6):1015-1021. PubMed ID: 28340150 [Abstract] [Full Text] [Related]
25. Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries. Chen S, Dizon JM, Hahn RT, Pibarot P, George I, Zhao Y, Blanke P, Kapadia S, Babaliaros V, Szeto WY, Makkar R, Thourani VH, Webb JG, Mack MJ, Leon MB, Kodali S, Nazif TM. JACC Cardiovasc Interv; 2024 Jun 10; 17(11):1325-1336. PubMed ID: 38866455 [Abstract] [Full Text] [Related]
26. The influence of native aortic valve calcium and transcatheter valve oversize on the need for pacemaker implantation after transcatheter aortic valve insertion. Al-Azzam F, Greason KL, Krittanawong C, Williamson EE, McLeod CJ, King KS, Mathew V. J Thorac Cardiovasc Surg; 2017 May 10; 153(5):1056-1062.e1. PubMed ID: 28073567 [Abstract] [Full Text] [Related]
28. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Fujita B, Kütting M, Seiffert M, Scholtz S, Egron S, Prashovikj E, Börgermann J, Schäfer T, Scholtz W, Preuss R, Gummert J, Steinseifer U, Ensminger SM. Eur Heart J Cardiovasc Imaging; 2016 Dec 10; 17(12):1385-1393. PubMed ID: 26758411 [Abstract] [Full Text] [Related]
29. Incidence, predictors, and clinical outcomes of permanent pacemaker insertion following transcatheter aortic valve implantation in an Arab population. Rajah FT, Alaamiri AA, Mahmoodurrahman M, Alhowaish TS, Aldosari SF, Hussain AO, Masuadi EM, Arifi AA, Balgaith MA, Ayoub KM, Almutairi FQ, Alanazi HA. J Interv Card Electrophysiol; 2022 Apr 10; 63(3):545-554. PubMed ID: 34427830 [Abstract] [Full Text] [Related]
33. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve. Oestreich BA, Mbai M, Gurevich S, Nijjar PS, Adabag S, Bertog S, Kelly R, Garcia S. Cardiovasc Revasc Med; 2018 Apr 10; 19(5 Pt B):626-631. PubMed ID: 29352699 [Abstract] [Full Text] [Related]
34. Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement. Matsushita K, Kanso M, Ohana M, Marchandot B, Kibler M, Heger J, Peillex M, Trimaille A, Hess S, Grunebaum L, Reydel A, De Poli F, Leddet P, Rischner J, Plastaras P, Jesel L, Morel O, Ohlmann P. Circ J; 2020 Sep 25; 84(10):1875-1883. PubMed ID: 32879221 [Abstract] [Full Text] [Related]
35. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience. Czerwińska K, Hryniewiecki T, Oręziak A, Dąbrowski M, Michałowska I, Witkowski A, Demkow M, Stępińska J, Orłowska Baranowska E, Rużyłło W. Kardiol Pol; 2012 Sep 25; 70(2):121-8. PubMed ID: 22427074 [Abstract] [Full Text] [Related]
36. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nørgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J. JACC Cardiovasc Interv; 2015 Mar 25; 8(3):462-471. PubMed ID: 25790764 [Abstract] [Full Text] [Related]
37. Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement. Maan A, Refaat MM, Heist EK, Passeri J, Inglessis I, Ptaszek L, Vlahakes G, Ruskin JN, Palacios I, Sundt T, Mansour M. Pacing Clin Electrophysiol; 2015 Jul 25; 38(7):878-86. PubMed ID: 25940067 [Abstract] [Full Text] [Related]
38. Implantation depth of balloon-expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events. Pellegrini C, Freißmuth M, Rheude T, Graas D, Mayr NP, Syryca F, Alvarez-Covarrubias HA, Fetcu A, Hübner J, Lennerz C, Schunkert H, Kastrati A, Xhepa E, Joner M. Catheter Cardiovasc Interv; 2023 Dec 25; 102(7):1301-1310. PubMed ID: 37877190 [Abstract] [Full Text] [Related]
39. Importance of the left ventricular outflow tract in the need for pacemaker implantation after transcatheter aortic valve replacement. Rodríguez-Olivares R, van Gils L, El Faquir N, Rahhab Z, Di Martino LF, van Weenen S, de Vries J, Galema TW, Geleijnse ML, Budde RP, Boersma E, de Jaegere PP, Van Mieghem NM. Int J Cardiol; 2016 Aug 01; 216():9-15. PubMed ID: 27135150 [Abstract] [Full Text] [Related]